Adoption of Liquid Biopsy Tests for NSCLC
Blood-based genomic tests are improving treatment decision and start times.
Read MorePosted by Steve Halasey | Jun 5, 2017 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics, Specimen Collection & Handling |
Blood-based genomic tests are improving treatment decision and start times.
Read MorePosted by Elaine Sanchez Wilson | May 25, 2017 | Coagulation Testing, Hematology & Serology, Molecular Diagnostics |
Respondents show significant interest in developing NGS-based tests for infectious disease testing applications.
Read MorePosted by Elaine Sanchez Wilson | May 23, 2017 | Cerebrovascular, Molecular Diagnostics, Sexually Transmitted Diseases, Stroke |
Clinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MorePosted by Elaine Sanchez Wilson | May 22, 2017 | Breast, Cancer, Molecular Diagnostics |
The comprehensive assessment of a patient’s biological health is designed to measure immune health status and detect genetic mutations associated with cancer.
Read MorePosted by Elaine Sanchez Wilson | May 22, 2017 | Molecular Diagnostics |
The future of precision medicine depends on IT-enabled pharmacogenomic testing.
Read More